While medications such as semaglutide (Ozempic), dulaglutide (Trulicity), and liraglutide (Victoza) have proven cardiovascular benefits, their potential influence on Read More GLP-1s and the Gut Microbiome: Emerging Insights Into GutMetabolic Interactions Feb 24, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, Obesity, Obesity, Type 2 Diabetes, Type 2 Diabetes 2,060 views The conversation around GLP-1 therapies has shifted quickly
OCD is driven in large part by dysregulation in the cortico-striato-thalamo-cortical (CSTC) circuit, which governs the loop between thought, urge, and compulsive response
62 Tirzepatide is also biased toward cAMP activation and the activity of -arrestin recruitment is lower than that of native GLP-1 for GLP-1R
10.1016/j.molcel.2018.01.024 184 MirzaeiH.GhorbaniS.KhanizadehS.NamdariH.FaghihlooE.AkbariA